1. UnitedHealth Group: The payer’s numerous acquisitions and renewed agreements bode well for its growth profile. Earnings increased by 20.21 percent in the last four quarters, on average. The expected long-term earnings growth rate stands at 12.8 percent.
2. Anthem: Acquisitions and collaborations have facilitated increased Medicare Advantage enrollment within the company. Earnings increased by 2.47 percent in the last four quarters on average, and its expected long-term earnings growth rate stands at 12.7 percent, according to Nasdaq.
3. Cigna: Nasdaq said the payer’s acquisition of Express Scripts, divesting its Group Life and Disability insurance business, and expansion of international business will be helpful in the long term. The company’s earnings increased by 5.43 percent in the last four quarters on average, while the expected long-term earnings growth rate sits at 11.5 percent.
4. Humana: The company has been performing well for several quarters, delivering an average 9.42 percent earnings increase in the last four quarters. Its expected long-term growth rate stands at 13.2 percent.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
